The Lancet-EASL Commission is tackling liver diseases in Europe and overcoming unmet needs, stigma and inequities. The Commission is quantifying the burden of liver disease in Europe and addressing optimal diagnosis and standards of care for patients with liver diseases…
A pioneering European research project, designed to develop new diagnostic tests to assess patients with Non-Alcoholic Fatty Liver Disease (NAFLD) has expanded giving access to more patients. Incorporating several new partners also enables access to even more state-of-the art technologies.…
EASL, the European Association for the Study of the Liver, is now calling for nominations for a new Scientific Committee member to join the Governing Board for a 3 year term starting in April 2020. European National Associations are invited…
Call for schools 2021 EASL would like to provide its members with the ability to participate by opening a call for programme outline proposals and proposed topics. In 2021, EASL plans to present two clinical and one basic school, to…
Professor Paolo Angeli has been elected Editor-in-Chief of the Journal of Hepatology – the flagship journal of the European Association for the Study of the Liver (EASL) Prof. Paolo Angeli was selected by the EASL Governing Board, with his appointment…
Health care professionals and patient groups are working together to find out more about the experience of patients with autoimmune liver conditions across Europe. The results of this survey will be used by EASL (The European Association for the Study…
Dear Colleague EASL has been commissioned by the UK journal, The Lancet to work together to create an EASL Lancet Commission on Liver Disease in Europe. I am chairing the Paediatric and Rare disease Group and we wish to identify…
Starting September 2019 Hainsworth will serve as the interface between the EASL Governing Board and the organisation`s Geneva and Brussels operations, ensuring high quality and effective implementation of the Governing Board`s policies and decisions. Hainsworth has worked for 25 years…
GENEVA, Switzerland Last week, ClarivateTM Analytics released the 2019 update of its Journal Citation Reports©, including the much anticipated 2018 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology achieved unprecedented results with a 2018 impact factor of 18.946,…
The public health community is greatly disappointed about the SpiritsEurope approach to label their products. In our view, the European spirits industry refrains from informing consumers at the point of sale in an easy and accessible manner. Instead of following…